Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
October 19, 2011
Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA's Gutierrez Provides Additional Clarity Regarding Oversight of DTC Genomics Firms
May 19, 2010 / Pharmacogenomics Reporter - DTC Genomics Gets Time Before FDA as Agency Considers Regulatory Strategy
July 21, 2010 / Pharmacogenomics Reporter - FDA Warns DTC Genomics Firms that Genetic Tests are Not LDTs, May Need Clearance or Approval
June 16, 2010 / Pharmacogenomics Reporter - Seeking 510(k) Clearance for Genomic Testing Service, 23andMe Maintains Direct-to-Consumer Ethos
August 1, 2012 / Pharmacogenomics Reporter - Latest Draft of Hatch IVD Bill Contains New Regulatory Proposals; Pricing Reforms under Discussion
July 6, 2011 / Pharmacogenomics Reporter